Kenvue Inc., founded on February 23, 2022, is a prominent American consumer health company headquartered in Skillman, New Jersey. Emerging from the Consumer Healthcare division of Johnson & Johnson, Kenvue's mission is to combine thoughtful everyday care with scientific precision. The company manages a portfolio of iconic brands such as Aveeno, Band-Aid, Benadryl, Johnson's Baby, Listerine, Mylanta, Neutrogena, Tylenol, and Visine, focusing on delivering health and wellness products to consumers worldwide.
Key figures at Kenvue include CEO Thibaut Mongon and Chairman Larry Merlo. The company is publicly traded on the NYSE under the ticker KVUE and is a component of the S&P 500. In 2023, Kenvue reported a revenue of $15.44 billion and an operating income of $2.512 billion. The company's impact is significant, touching the lives of over a billion people globally through its trusted brands and commitment to innovation in consumer health.
